Upcoming Webinar:
For the production of inhalable particles, an initial development phase at the lab scale is typically recommended to optimize the main particle properties and consequently, product performance and physio-chemical stability. As the product moves along the clinical phases, the spray drying process may require scale-up. Upon scale-up it is critical to ensure that the powder quality attributes are maintained across scales, namely particle size, density and residual water content, as these dictate product performance.
In the pharmaceutical industry, spray drying presents multiple advantages as a particle engineering technology, especially for the production of carrier-free dry powder inhalation formulations. Spray Drying technology is simple, flexible, fully automated and adapted to continuous production, easily scalable and even suitable for the processing of labile drugs such as proteins.
Key learning objectives:
1. Fundamentals of Spray Drying processes for Inhalation products
2. Development Methodologies: Statistical and Mechanistical
3. Process Screening, Optimization and Intensification
4. Scale-up Methodologies: From lab to commercial production
Hope you can join us!
To Know more about Hovione, visit our website:
Speaker:
Eunice Costa
Scientist
Speaker:
Cláudia Moura
Researcher Scientist
Duration
30 minutes + 10 minutes Q&A
Attending this webinar is free,
all you need to do is register your place above
Speakers:
Date
2nd of December 2015
Time Option 1
04:00 pm (London time)
08:00 am (PST)
11:00 am (EST)
Time Option 2
02:00 pm (London time)
09:00 am (EST)